Under the deal, Bacterin has acquired X-spine’s outstanding shares in exchange for around 4.24 million shares of the firm and about $60m in cash.
The deal will help Bacterin to expand its product portfolio that can be used in a wide range of orthopedic and spine surgical procedures.
Based in Miamisburg of Ohio, X-spine manufactures multiple products to treat spinal disease and is expertised in hardware offering that will allow Bacterin to focus more on orthopedic and spine surgical procedures.
The firm’s spinal implants and instrumentation will expand Bacterin’s orthobiologics portfolio, allowing to offer less-invasive treatments for the degenerative spine.
Bacterin produces products that are used in applications, including enhancing fusion in spine surgery, relief of back pain and promotion of bone growth in foot and ankle surgery, as well as other joint surgeries.
